McKesson In Final Phase Of Negotiating Fee-For-Service Contracts
This article was originally published in The Pink Sheet Daily
Executive Summary
The wholesaler anticipates 80% of compensation from manufacturers will be recorded under the new contract model by Oct. 1. Pfizer continues to be a significant holdout within the transition to fee-for-service, McKesson says.